Latency-Associated Degradation of the MRP1 Drug Transporter During Latent Human Cytomegalovirus Infection

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification

Cox, J., & Mann, M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1511 · Cited by 14,855 · see citing works

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview

Schinkel, A. H., & Jonker, J. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00169-2 · Cited by 1,427 · see citing works

Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview

Schinkel, A. H., & Jonker, J. W. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.027 · Cited by 1,236 · see citing works

Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells

Taylor‐Wiedeman, J., Sissons, J. G. P., Borysiewicz, L. K., & Sinclair, J. H. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-9-2059 · Cited by 700 · see citing works

Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

Hahn, G., Jores, R. D., & Mocarski, E. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3937 · Cited by 514 · see citing works

The Leukotriene C4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes

Robbiani, D. F., Finch, R. A., Jäger, D., Müller, W. A., Sartorelli, A. C., & Randolph, G. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00179-3 · Cited by 455 · see citing works

High Risk of Death Due to Bacterial and Fungal Infection among Cytomegalovirus (CMV)–Seronegative Recipients of Stem Cell Transplants from Seropositive Donors: Evidence for Indirect Effects of Primary CMV Infection

Nichols, W. G., Corey, L., Gooley, T. A., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338624 · Cited by 426 · see citing works

Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers

Reeves, M. B., MacAry, P. A., Lehner, P. J., Sissons, J. G. P., & Sinclair, J. H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408994102 · Cited by 360 · see citing works

Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.

Kondo, K., Kaneshima, H., & Mocarski, E. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11879 · Cited by 355 · see citing works

The MTT [3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide] Assay Is a Fast and Reliable Method for Colorimetric Determination of Fungal Cell Densities

Freimoser, F. M., Jakob, C. A., Aebi, M., & Tuor, U. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.8.3727-3729.1999 · Cited by 316 · see citing works

Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency

Goodrum, F. D., Jordan, C. T., High, K. P., & Shenk, T. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252630899 · Cited by 255 · see citing works

Human cytomegalovirus: Latency and reactivation in the myeloid lineage

Sinclair, J. H. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.11.014 · Cited by 245 · see citing works

Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro

Goodrum, F. D., Reeves, M. B., Sinclair, J. H., et al. (2007) · Blood · doi:10.1182/blood-2007-01-070078 · Cited by 228 · see citing works

Reevaluation of human cytomegalovirus coding potential

Murphy, E. A., Rigoutsos, I., Shibuya, T., & Shenk, T. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735466100 · Cited by 199 · see citing works

Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101‐dependent degradation

Hewitt, E. W., Duncan, L., Mufti, D., Baker, J., Stevenson, P. G., & Lehner, P. J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2418 · Cited by 197 · see citing works

Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity

Thomas, M., Boname, J. M., Field, S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707883105 · Cited by 176 · see citing works

Experimental human cytomegalovirus latency in CD14 + monocytes

Hargett, D., & Shenk, T. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014509107 · Cited by 162 · see citing works

An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling

Reeves, M. B., Lehner, P. J., Sissons, J. G. P., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.81161-0 · Cited by 161 · see citing works

Hyperplexing: a method for higher-order multiplexed quantitative proteomics provides a map of the dynamic response to rapamycin in yeast

Dephoure, N., & Gygi, S. P. (2012) · Science Signaling · doi:10.1126/scisignal.2002548 · Cited by 153 · see citing works

Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell.

Almquist, K. C., Loe, D. W., Hipfner, D. R., Mackie, J. E., Cole, S. P. C., & Deeley, R. G. (1995) · PubMed · Cited by 146 · see citing works

HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation

Burr, M. L., Cano, F., Svobodova, S., Boyle, L. H., Boname, J. M., & Lehner, P. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016229108 · Cited by 136 · see citing works

Differential outcomes of human cytomegalovirus infection in primitive hematopoietic cell subpopulations

Goodrum, F. D., Jordan, C. T., Terhune, S. S., High, K. P., & Shenk, T. E. (2004) · Blood · doi:10.1182/blood-2003-12-4344 · Cited by 136 · see citing works

Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein.

Marquardt, D., McCrone, S., & M S Center (1990) · PubMed · Cited by 117 · see citing works

Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection

Sinclair, J. H. (2009) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.08.001 · Cited by 110 · see citing works

Characterization of a Novel Golgi Apparatus-Localized Latency Determinant Encoded by Human Cytomegalovirus

Petrucelli, A., Rak, M. A., Grainger, L. A., & Goodrum, F. D. (2009) · Journal of Virology · doi:10.1128/jvi.01989-08 · Cited by 107 · see citing works

Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34+ progenitors

Poole, E. L., Dallas, S. R. M., Colston, J., et al. (2011) · Journal of General Virology · doi:10.1099/vir.0.031377-0 · Cited by 90 · see citing works

Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4 + T-cell migration and suppression of effector function

Mason, G. M., Poole, E. L., Sissons, J. G. P., Wills, M. R., & Sinclair, J. H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204836109 · Cited by 87 · see citing works

The Cytomegaloviral Protein pUL138 Acts as Potentiator of Tumor Necrosis Factor (TNF) Receptor 1 Surface Density To Enhance ULb′-Encoded Modulation of TNF-α Signaling

Le‐Trilling, V. T. K., Trilling, M., & Hengel, H. (2011) · Journal of Virology · doi:10.1128/jvi.06005-11 · Cited by 84 · see citing works

Proteomic Plasma Membrane Profiling Reveals an Essential Role for gp96 in the Cell Surface Expression of LDLR Family Members, Including the LDL Receptor and LRP6

Weekes, M. P., Antrobus, R., Talbot, S., Hör, S., Simecek, N., Smith, D. L., Bloor, S., Randow, F., & Lehner, P. J. (2012) · Journal of Proteome Research · doi:10.1021/pr201135e · Cited by 80 · see citing works

Human Cytomegalovirus Infection Inhibits Tumor Necrosis Factor Alpha (TNF-α) Signaling by Targeting the 55-Kilodalton TNF-α Receptor

Baillie, J., Sahlender, D. A., & Sinclair, J. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.7007-7016.2003 · Cited by 77 · see citing works

The Latency-Associated UL138 Gene Product of Human Cytomegalovirus Sensitizes Cells to Tumor Necrosis Factor Alpha (TNF-α) Signaling by Upregulating TNF-α Receptor 1 Cell Surface Expression

Montag, C., Wagner, J. A., Gruska, I., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05028-11 · Cited by 76 · see citing works

Comparative analysis of techniques to purify plasma membrane proteins.

Weekes, M. P., Antrobus, R., Lill, J. R., Duncan, L. M., Hör, S., & Lehner, P. J. (2010) · PubMed Central · Cited by 73 · see citing works

Stress-Inducible Alternative Translation Initiation of Human Cytomegalovirus Latency Protein pUL138

Grainger, L. A., Cicchini, L., Rak, M. A., Petrucelli, A., Fitzgerald, K. D., Semler, B. L., & Goodrum, F. D. (2010) · Journal of Virology · doi:10.1128/jvi.00855-10 · Cited by 67 · see citing works

Dendritic Cells Require Multidrug Resistance Protein 1 (ABCC1) Transporter Activity for Differentiation

van de Ven, R., de Jong, M. C., Reurs, A. W., Schoonderwoerd, A., Jansen, G., Hooijberg, J. H., Scheffer, G. L., de Gruijl, T. D., & Scheper, R. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5191 · Cited by 63 · see citing works

Human Cytomegalovirus Latent Infection and Associated Viral Gene Expression

Slobedman, B., Cao, J. Z., Avdic, S., et al. (2010) · Future Microbiology · doi:10.2217/fmb.10.58 · Cited by 56 · see citing works

Viral Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection Modulates Latently Infected Myeloid Cell Differentiation

Avdic, S., Cao, J. Z., Cheung, A. K. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00088-11 · Cited by 53 · see citing works

Efficient Human Cytomegalovirus Reactivation Is Maturation Dependent in the Langerhans Dendritic Cell Lineage and Can Be Studied using a CD14+Experimental Latency Model

Huang, M. M., Kew, V. G., Jestice, K., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00598-12 · Cited by 49 · see citing works

In vivo analysis of human multidrug resistance protein 1 (MRP1) activity using transient expression of fluorescently tagged MRP1.

Rajagopal, A., Pant, A. C., Simon, S. M., et al. (2002) · PubMed · Cited by 36 · see citing works

Human Cytomegaloviruses Expressing Yellow Fluorescent Fusion Proteins - Characterization and Use in Antiviral Screening

Straschewski, S., Warmer, M., Frascaroli, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009174 · Cited by 26 · see citing works

UL84-independent replication of human cytomegalovirus strain TB40/E

Spector, D. J., & Yetming, K. D. (2010) · Virology · doi:10.1016/j.virol.2010.08.029 · Cited by 23 · see citing works

A new 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay for testing macrophage cytotoxicity to L1210 and its drug-resistant cell lines in vitro

Jiao, H., Shen, W., Ohe, Y., et al. (1992) · Cancer Immunology Immunotherapy · doi:10.1007/bf01789020 · Cited by 23 · see citing works

The pH sensitive probe 5‐(and‐6)‐carboxyl seminaphthorhodafluor is a substrate for the multidrug resistance‐related protein MRP1

Jin, J., & Jones, A. T. (2008) · International Journal of Cancer · doi:10.1002/ijc.23892 · Cited by 9 · see citing works

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Burr, M. L., Sparbier, C. E., Chan, Y.-C., Williamson, J. C., Woods, K., Beavis, P. A., Lam, E. Y. N., Henderson, M. A., Bell, C. C., Stolzenburg, S., et al. (2017) · Nature · doi:10.1038/nature23643 · Cited by 946 · see citing works

NOTCH1 mediates a switch between two distinct secretomes during senescence

Hoare, M., Ito, Y., Kang, T.-W., Weekes, M. P., Matheson, N. J., Patten, D. A., Shetty, S., Parry, A. J., Menon, S., Salama, R., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3397 · Cited by 522 · see citing works

The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology

Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67 · see citing works

Rethinking human cytomegalovirus latency reservoir

Schwartz, M., & Stern‐Ginossar, N. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14994 · Cited by 35 · see citing works

Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection

Krishna, B. A., Poole, E. L., Jackson, S. E., Smit, M. J., Wills, M. R., & Sinclair, J. H. (2017) · mBio · doi:10.1128/mbio.01754-17 · Cited by 102 · see citing works

Human Cytomegalovirus Manipulation of Latently Infected Cells

Sinclair, J. H., & Reeves, M. B. (2013) · Viruses · doi:10.3390/v5112803 · Cited by 38 · see citing works

HIV-1 latency in proliferating T cells

van der Sluis, R. M. (2013) · UvA-DARE (University of Amsterdam)

Molecular Control of HIV and SIV Latency

Darcis, G., Driessche, B. V., Bouchat, S., Kirchhoff, F., & Lint, C. M. V. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_74 · Cited by 16 · see citing works